Africa
New data for Novartis drug Lucentis® reinforces transformational efficacy and well-established safety profile across four indications
New clinical and real world data for Lucentis® (ranibizumab) presented in over 40 abstracts at this week’s EURETINA congress confirm its transformational and well-established safety profile in four retinal diseases. Designed for intraocular use, Lucentis […]